Global innovation in colorectal cancer care meets growing regional need in the Middle East DUBAI, RIYADH, DOHA, March 26, 2026. During Colorectal Cancer Awareness Month, Memorial Sloan Kettering Cancer Center (MSK) is spotlighting advances in colorectal cancer care, while emphasizing the importance of screening, early detection, and access to specialized treatment for patients across the … Continue reading During Colorectal Cancer Awareness Month, Memorial Sloan Kettering Cancer Center Showcases New Advances in Care

Combining artificial intelligence and nanoscale sensors, the research demonstrates a new approach that could potentially detect and distinguish different types of brain tumors DUBAI, RIYADH, DOHA 19 January 2026 - Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed an ultrasensitive diagnostic test that could change how brain tumors are detected, offering a less invasive … Continue reading AI-Powered Blood Test Could Transform Brain Tumor Diagnosis, Memorial Sloan Kettering Researchers Say

Unveiled at ASCO 2025, global trials and innovative therapies in immunotherapy, early detection and supportive care demonstrate MSK’s leadership in setting new international standards for cancer treatment and survivorship DUBAI, RIYADH, June 23, 2025. Memorial Sloan Kettering Cancer Center (MSK), a world-renowned leader in cancer treatment and research, has announced groundbreaking data at the 2025 … Continue reading New cancer breakthroughs from Memorial Sloan Kettering Cancer Center offer new hope for patients around the world, including in the Middle East

80% of patients with locally advanced mismatch repair-deficient (MMRd) solid tumors who were treated with immunotherapy avoided surgery DUBAI, RIYADH, May 6, 2025—New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea Cercek, MD, and Luis Diaz Jr., MD, demonstrate how immunotherapy alone can allow people with MMRd … Continue reading Immunotherapy Could Replace Surgery, Enabling Patients To Retain Their Organs and Enhance Their Quality of Life

البرفسور الدكتور غسان أبو علفا: هدف مركز ميموريال سلون كيترينغ لعلاج السرطان من المشاركة في مؤتمر الصحة العربي هو تأكيد التزامنا بعلاج مرضى الأورام في  منطقة الخليج العربي وحول العالم دبي، الإمارات العربية المتحدة، 30 يناير: يشارك مركز ميموريال سلون كيترينغ لعلاج السرطان الرائد عالميًا في علاج المرضى، وتعليم الأطباء، واجراء الأبحاث العلمية لأمراض الأورام، في مؤتمر الصحة العربي لأول مرة هذا العام.           ويعمل … Continue reading البرفسورالدكتور غسان أبو علفا: هدف مركز ميموريال سلون كيترينغ لعلاج السرطان من المشاركة في مؤتمر الصحة العربي هو تأكيد التزامنا بعلاج مرضى الأورام في  منطقة الخليج العربي وحول العالم